Optimizing Treatment Strategies for Egfr -Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights.
Saved in:
| Title: | Optimizing Treatment Strategies for Egfr -Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights. |
|---|---|
| Authors: | Thomas, Quentin Dominique1 (AUTHOR) quentin.thomas@icm.unicancer.fr, Girard, Nicolas2 (AUTHOR) nicolas.girard2@curie.fr, Bosquet, Lise3 (AUTHOR) l-bosquet@unicancer.fr, Cavaillon, Sarah1 (AUTHOR) xavier.quantin@icm.unicancer.fr, Filleron, Thomas4 (AUTHOR) filleron.thomas@iuct-oncopole.fr, Eltaief, Siham3 (AUTHOR) s-eltaief@unicancer.fr, Chouaid, Christos5 (AUTHOR) christos.chouaid@chicreteil.fr, Lena, Hervé6 (AUTHOR) herve.lena@chu-rennes.fr, Debieuvre, Didier7 (AUTHOR) debieuvred@ghrmsa.fr, Perol, Maurice8 (AUTHOR) maurice.perol@lyon.unicancer.fr, Quantin, Xavier1 (AUTHOR) |
| Source: | Cancers. Nov2024, Vol. 16 Issue 21, p3563. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers16213563 |
